Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 373

1.

Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment.

Gentile M, Shanafelt TD, Mauro FR, Reda G, Rossi D, Laurenti L, Del Principe MI, Cutrona G, Angeletti I, Coscia M, Herishanu Y, Chiarenza A, Molica S, Ciolli S, Goldschmidt N, Angrilli F, Giordano A, Rago A, Bairey O, Tripepi G, Chaffee KG, Sameer PA, Vigna E, Zirlik K, Shvidel L, Innocenti I, Recchia AG, Di Raimondo F, Del Poeta G, Cortelezzi A, Neri A, Ferrarini M, Gaidano G, Kay NE, Polliack A, Foà R, Morabito F.

Eur J Haematol. 2018 Jul 24. doi: 10.1111/ejh.13149. [Epub ahead of print]

PMID:
30039576
2.

Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases.

Morabito F, Shanafelt TD, Gentile M, Reda G, Mauro FR, Rossi D, Di Renzo N, Molica S, Angrilli F, Chiarenza A, Cutrona G, Chaffee KG, Parikh SA, Tripepi G, D'Arrigo G, Vigna E, Recchia AG, Cortelezzi A, Gaidano G, Di Raimondo F, Fais F, Foà R, Neri A, Ferrarini M.

Am J Hematol. 2018 Jul 9. doi: 10.1002/ajh.25206. [Epub ahead of print] No abstract available.

PMID:
29984867
3.

Trypanosoma cruzi XRNA granules colocalise with distinct mRNP granules at the nuclear periphery.

Costa JFD, Ferrarini MG, Nardelli SC, Goldenberg S, Ávila AR, Holetz FB.

Mem Inst Oswaldo Cruz. 2018;113(6):e170531. doi: 10.1590/0074-02760170531. Epub 2018 Jun 18.

4.

The fibrogenic chemokine CCL18 is associated with disease severity in Erdheim-Chester disease.

Pacini G, Cavalli G, Tomelleri A, De Luca G, Pacini G, Ferrarini M, Doglioni C, Dagna L.

Oncoimmunology. 2018 Mar 15;7(7):e1440929. doi: 10.1080/2162402X.2018.1440929. eCollection 2018.

PMID:
29900045
5.

Implanting neochordae for the repair of mitral valve prolapse using a prosthetic ring with chordal sizing system: a modified technique for myxomatous leaflets.

Lio A, Miceli A, Ferrarini M, Montisci A, Glauber M.

Multimed Man Cardiothorac Surg. 2018 May 8;2018. doi: 10.1510/mmcts.2018.023.

6.

Sutureless Prosthesis Implantation and Ascending Aorta Replacement Through a Ministernotomy Approach.

Lio A, Ferrarini M, Miceli A, Glauber M.

Innovations (Phila). 2018 May/Jun;13(3):239-241. doi: 10.1097/IMI.0000000000000479.

PMID:
29742534
7.

Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab.

Gentile M, Shanafelt TD, Reda G, Mauro FR, Zirlik K, Ciolli S, Laurenti L, Del Principe MI, Rossi D, Di Renzo N, Molica S, Angrilli F, Coscia M, Chiarenza A, Giordano A, Cutrona G, Chaffee KG, Parikh SA, Uccello G, Innocenti I, Tripepi G, D'Arrigo G, Vigna E, Recchia AG, Herishanu Y, Shvidel L, Tadmor T, Cortelezzi A, Del Poeta G, Gaidano G, Di Raimondo F, Neri A, Ferrarini M, Foà R, Polliack A, Morabito F.

Leukemia. 2018 Aug;32(8):1869-1873. doi: 10.1038/s41375-018-0100-6. Epub 2018 Mar 20. No abstract available.

PMID:
29588545
8.

Mitral valve repair and aortic valve replacement with sutureless prosthesis implantation through a right minithoracotomy.

Lio A, Miceli A, Ferrarini M, Glauber M.

Multimed Man Cardiothorac Surg. 2017 May 4;2017. doi: 10.1510/mmcts.2017.008.

9.

Sutureless Perceval Aortic Valve Versus Conventional Stented Bioprostheses: Meta-Analysis of Postoperative and Midterm Results in Isolated Aortic Valve Replacement.

Meco M, Montisci A, Miceli A, Panisi P, Donatelli F, Cirri S, Ferrarini M, Lio A, Glauber M.

J Am Heart Assoc. 2018 Feb 16;7(4). pii: e006091. doi: 10.1161/JAHA.117.006091. Review.

10.

Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolence.

Cutrona G, Tripodo C, Matis S, Recchia AG, Massucco C, Fabbi M, Colombo M, Emionite L, Sangaletti S, Gulino A, Reverberi D, Massara R, Boccardo S, de Totero D, Salvi S, Cilli M, Pellicanò M, Manzoni M, Fabris S, Airoldi I, Valdora F, Ferrini S, Gentile M, Vigna E, Bossio S, De Stefano L, Palummo A, Iaquinta G, Cardillo M, Zupo S, Cerruti G, Ibatici A, Neri A, Fais F, Ferrarini M, Morabito F.

Sci Transl Med. 2018 Feb 14;10(428). pii: eaal1571. doi: 10.1126/scitranslmed.aal1571.

PMID:
29444977
11.

Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3D surrogate microenvironment.

Belloni D, Heltai S, Ponzoni M, Villa A, Vergani B, Pecciarini L, Marcatti M, Girlanda S, Tonon G, Ciceri F, Caligaris-Cappio F, Ferrarini M, Ferrero E.

Haematologica. 2018 Apr;103(4):707-716. doi: 10.3324/haematol.2017.167486. Epub 2018 Jan 11.

12.

Mitral valve repair using a prosthetic ring with chordal sizing system: a modified technique in the presence of myxomatous leaflets.

Lio A, Miceli A, Ferrarini M, Glauber M.

Eur J Cardiothorac Surg. 2017 Oct 1;52(4):820-822. doi: 10.1093/ejcts/ezx229.

PMID:
29156012
13.

The spectrum of Charcot-Marie-Tooth disease due to myelin protein zero: An electrodiagnostic, nerve ultrasound and histological study.

Fabrizi GM, Tamburin S, Cavallaro T, Cabrini I, Ferrarini M, Taioli F, Magrinelli F, Zanette G.

Clin Neurophysiol. 2018 Jan;129(1):21-32. doi: 10.1016/j.clinph.2017.09.117. Epub 2017 Oct 20.

PMID:
29136549
14.

Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases.

Gentile M, Shanafelt TD, Mauro FR, Laurenti L, Rossi D, Molica S, Vincelli I, Cutrona G, Uccello G, Pepe S, Vigna E, Tripepi G, Chaffee KG, Parikh SA, Bossio S, Recchia AG, Innocenti I, Pasquale R, Neri A, Ferrarini M, Gaidano G, Foà R, Morabito F.

Am J Hematol. 2018 Feb;93(2):E35-E37. doi: 10.1002/ajh.24960. Epub 2017 Nov 23. No abstract available.

PMID:
29098721
15.

Sutureless aortic valve replacement versus transcatheter aortic valve implantation: a meta-analysis of comparative matched studies using propensity score matching.

Meco M, Miceli A, Montisci A, Donatelli F, Cirri S, Ferrarini M, Lio A, Glauber M.

Interact Cardiovasc Thorac Surg. 2018 Feb 1;26(2):202-209. doi: 10.1093/icvts/ivx294.

PMID:
29049787
16.

Tocilizumab in patients with multisystem Erdheim-Chester disease.

Berti A, Cavalli G, Guglielmi B, Biavasco R, Campochiaro C, Tomelleri A, Nicoletti R, Panzacchi A, Ferrarini M, Dagna L.

Oncoimmunology. 2017 Apr 20;6(6):e1318237. doi: 10.1080/2162402X.2017.1318237. eCollection 2017.

17.

3D-Dynamic Culture Models of Multiple Myeloma.

Ferrarini M, Steimberg N, Boniotti J, Berenzi A, Belloni D, Mazzoleni G, Ferrero E.

Methods Mol Biol. 2017;1612:177-190. doi: 10.1007/978-1-4939-7021-6_13.

PMID:
28634943
18.

Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemia.

Mauro FR, Morabito F, Vincelli ID, Petrucci L, Campanelli M, Salaroli A, Uccello G, Petrungaro A, Ronco F, Raponi S, Nanni M, Neri A, Ferrarini M, Guarini AR, Foà R, Gentile M.

Leuk Res. 2017 Jun;57:65-71. doi: 10.1016/j.leukres.2017.02.011. Epub 2017 Feb 27.

PMID:
28292720
19.

A new mechanism shapes the naïve CD8+ T cell repertoire: the selection for full diversity.

Gonçalves P, Ferrarini M, Molina-Paris C, Lythe G, Vasseur F, Lim A, Rocha B, Azogui O.

Mol Immunol. 2017 May;85:66-80. doi: 10.1016/j.molimm.2017.01.026. Epub 2017 Mar 8.

20.

Mitral valve repair and aortic valve replacement with sutureless prosthesis implantation through a right minithoracotomy.

Lio A, Miceli A, Ferrarini M, Glauber M.

Multimed Man Cardiothorac Surg. 2016 Dec 14;2017. doi: 10.1510/mmcts.2016.019.

21.

Heterogeneous expression of the collagen receptor DDR1 in chronic lymphocytic leukaemia and correlation with progression.

Barisione G, Fabbi M, Cutrona G, De Cecco L, Zupo S, Leitinger B, Gentile M, Manzoni M, Neri A, Morabito F, Ferrarini M, Ferrini S.

Blood Cancer J. 2017 Jan 6;6(1):e513. doi: 10.1038/bcj.2016.121. No abstract available.

22.

Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy.

Cutrona G, Matis S, Colombo M, Massucco C, Baio G, Valdora F, Emionite L, Fabris S, Recchia AG, Gentile M, Neumaier CE, Reverberi D, Massara R, Boccardo S, Basso L, Salvi S, Rosa F, Cilli M, Zupo S, Truini M, Tassone P, Calabrese M, Negrini M, Neri A, Morabito F, Fais F, Ferrarini M.

Leukemia. 2017 Sep;31(9):1894-1904. doi: 10.1038/leu.2016.394. Epub 2017 Jan 5.

PMID:
28053325
23.

The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients.

Molica S, Shanafelt TD, Giannarelli D, Gentile M, Mirabelli R, Cutrona G, Levato L, Di Renzo N, Di Raimondo F, Musolino C, Angrilli F, Famà A, Recchia AG, Chaffee KG, Neri A, Kay NE, Ferrarini M, Morabito F.

Am J Hematol. 2016 Nov;91(11):1090-1095. doi: 10.1002/ajh.24493. Epub 2016 Aug 8.

24.

Progressive Myoclonus Epilepsy in Congenital Generalized Lipodystrophy type 2: Report of 3 cases and literature review.

Opri R, Fabrizi GM, Cantalupo G, Ferrarini M, Simonati A, Dalla Bernardina B, Darra F.

Seizure. 2016 Nov;42:1-6. doi: 10.1016/j.seizure.2016.08.008. Epub 2016 Sep 5. Review.

25.

Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease.

Ferrero E, Corti A, Haroche J, Belloni D, Colombo B, Berti A, Cavalli G, Campochiaro C, Villa A, Cohen-Aubart F, Amoura Z, Doglioni C, Dagna L, Ferrarini M.

Oncoimmunology. 2016 May 5;5(7):e1181244. doi: 10.1080/2162402X.2016.1181244. eCollection 2016 Jul.

26.

lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome.

Ronchetti D, Manzoni M, Agnelli L, Vinci C, Fabris S, Cutrona G, Matis S, Colombo M, Galletti S, Taiana E, Recchia AG, Bossio S, Gentile M, Musolino C, Di Raimondo F, Grilli A, Bicciato S, Cortelezzi A, Tassone P, Morabito F, Ferrarini M, Neri A.

Blood Cancer J. 2016 Sep 9;6(9):e468. doi: 10.1038/bcj.2016.77.

27.

Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients.

Gentile M, Shanafelt TD, Rossi D, Laurenti L, Mauro FR, Molica S, Cutrona G, Uccello G, Campanelli M, Vigna E, Tripepi G, Chaffee KG, Parikh SA, Bossio S, Recchia AG, Innocenti I, Pasquale R, Neri A, Ferrarini M, Gaidano G, Foà R, Morabito F.

Blood. 2016 Oct 20;128(16):2093-2095. doi: 10.1182/blood-2016-07-728261. Epub 2016 Aug 22. No abstract available.

28.

International Expert Consensus on Sutureless and Rapid Deployment Valves in Aortic Valve Replacement Using Minimally Invasive Approaches.

Glauber M, Moten SC, Quaini E, Solinas M, Folliguet TA, Meuris B, Miceli A, Oberwalder PJ, Rambaldini M, Teoh KH, Bhatnagar G, Borger MA, Bouchard D, Bouchot O, Clark SC, Dapunt OE, Ferrarini M, Fischlein TJ, Laufer G, Mignosa C, Millner R, Noirhomme P, Pfeiffer S, Ruyra-Baliarda X, Shrestha ML, Suri RM, Troise G, Gersak B.

Innovations (Phila). 2016 May-Jun;11(3):165-73. doi: 10.1097/IMI.0000000000000287.

29.

A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI).

Valdora F, Cutrona G, Matis S, Morabito F, Massucco C, Emionite L, Boccardo S, Basso L, Recchia AG, Salvi S, Rosa F, Gentile M, Ravina M, Pace D, Castronovo A, Cilli M, Truini M, Calabrese M, Neri A, Neumaier CE, Fais F, Baio G, Ferrarini M.

Clin Immunol. 2016 Nov;172:52-60. doi: 10.1016/j.clim.2016.07.013. Epub 2016 Jul 16.

30.

Minimally invasive approach for aortic and mitral valve surgery.

Lio A, Miceli A, Ferrarini M, Glauber M.

Eur J Cardiothorac Surg. 2016 Dec;50(6):1204-1205. doi: 10.1093/ejcts/ezw208. Epub 2016 Jun 14.

PMID:
27301388
31.

Erratum to "Charcot-Marie-Tooth type 2 and distal hereditary motor neuropathy: Clinical, neurophysiological and genetic findings from a single-centre experience" [Clin. Neurol. Neurosurg. 144 (2016) 67-71].

Luigetti M, Fabrizi GM, Bisogni G, Romano A, Taioli F, Ferrarini M, Bernardo D, Rossini PM, Sabatelli M.

Clin Neurol Neurosurg. 2016 Jun 2. pii: S0303-8467(16)30182-2. doi: 10.1016/j.clineuro.2016.05.011. [Epub ahead of print] No abstract available.

PMID:
27265096
32.

Perceval S Valve Solution for Degenerated Freestyle Root in the Presence of Chronic Aortic Dissection.

Lio A, Miceli A, Ferrarini M, Glauber M.

Ann Thorac Surg. 2016 Jun;101(6):2365-7. doi: 10.1016/j.athoracsur.2015.09.012.

PMID:
27211946
33.

Insights on the virulence of swine respiratory tract mycoplasmas through genome-scale metabolic modeling.

Ferrarini MG, Siqueira FM, Mucha SG, Palama TL, Jobard É, Elena-Herrmann B, R Vasconcelos AT, Tardy F, Schrank IS, Zaha A, Sagot MF.

BMC Genomics. 2016 May 13;17:353. doi: 10.1186/s12864-016-2644-z.

34.

The OECI certification/designation program: the Genoa experience.

Orengo G, Pronzato P, Ferrarini M.

Tumori. 2015;101 Suppl 1:S19-20. doi: 10.5301/tj.5000457. Epub 2015 Dec 30.

PMID:
27096267
35.

Charcot-Marie-Tooth type 2 and distal hereditary motor neuropathy: Clinical, neurophysiological and genetic findings from a single-centre experience.

Luigetti M, Fabrizi GM, Bisogni G, Romano A, Taioli F, Ferrarini M, Bernardo D, Rossini PM, Sabatelli M.

Clin Neurol Neurosurg. 2016 May;144:67-71. doi: 10.1016/j.clineuro.2016.03.007. Epub 2016 Mar 9.

PMID:
26989944
36.

Septic arthritis by Sphingobacterium multivorum in imunocompromised pediatric patient.

Mendes MD, Cavallo RR, Carvalhães CH, Ferrarini MA.

Rev Paul Pediatr. 2016 Sep;34(3):379-83. doi: 10.1016/j.rpped.2015.12.001. Epub 2016 Feb 1. English, Portuguese.

37.

Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients.

Bianco M, Gasparri AM, Colombo B, Curnis F, Girlanda S, Ponzoni M, Bertilaccio MT, Calcinotto A, Sacchi A, Ferrero E, Ferrarini M, Chesi M, Bergsagel PL, Bellone M, Tonon G, Ciceri F, Marcatti M, Caligaris-Cappio F, Corti A.

Cancer Res. 2016 Apr 1;76(7):1781-91. doi: 10.1158/0008-5472.CAN-15-1637. Epub 2016 Feb 11.

38.

HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment.

Valsecchi R, Coltella N, Belloni D, Ponente M, Ten Hacken E, Scielzo C, Scarfò L, Bertilaccio MT, Brambilla P, Lenti E, Martinelli Boneschi F, Brendolan A, Ferrero E, Ferrarini M, Ghia P, Tonon G, Ponzoni M, Caligaris-Cappio F, Bernardi R.

Blood. 2016 Apr 21;127(16):1987-97. doi: 10.1182/blood-2015-07-657056. Epub 2016 Jan 29.

39.

A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients.

Gentile M, Shanafelt TD, Cutrona G, Molica S, Tripepi G, Alvarez I, Mauro FR, Di Renzo N, Di Raimondo F, Vincelli I, Todoerti K, Matis S, Musolino C, Fabris S, Vigna E, Levato L, Zupo S, Angrilli F, Consoli U, Festini G, Longo G, Cortelezzi A, Arcari A, Federico M, Mannina D, Recchia AG, Neri A, Kay NE, Ferrarini M, Morabito F.

Leukemia. 2016 Jun;30(6):1440-3. doi: 10.1038/leu.2015.333. Epub 2015 Dec 9. No abstract available.

PMID:
26648537
40.

Early and long-term outcomes of minimally invasive mitral valve surgery through right minithoracotomy: a 10-year experience in 1604 patients.

Glauber M, Miceli A, Canarutto D, Lio A, Murzi M, Gilmanov D, Ferrarini M, Farneti PA, Quaini EL, Solinas M.

J Cardiothorac Surg. 2015 Dec 7;10:181. doi: 10.1186/s13019-015-0390-y.

41.

Alliance Against Cancer, the network of Italian cancer centers bridging research and care.

De Paoli P, Ciliberto G, Ferrarini M, Pelicci P, Dellabona P, De Lorenzo F, Mantovani A, Musto P, Opocher G, Picci P, Ricciardi W, De Maria R.

J Transl Med. 2015 Nov 14;13:360. doi: 10.1186/s12967-015-0711-x.

42.

Minimally invasive mitral valve repair through right minithoracotomy in the setting of degenerative mitral regurgitation: early outcomes and long-term follow-up.

Miceli A, Murzi M, Canarutto D, Gilmanov D, Ferrarini M, Farneti PA, Solinas M, Glauber M.

Ann Cardiothorac Surg. 2015 Sep;4(5):422-7. doi: 10.3978/j.issn.2225-319X.2015.04.10.

43.

Sutureless, rapid deployment valves and stented bioprosthesis in aortic valve replacement: recommendations of an International Expert Consensus Panel.

Gersak B, Fischlein T, Folliguet TA, Meuris B, Teoh KH, Moten SC, Solinas M, Miceli A, Oberwalder PJ, Rambaldini M, Bhatnagar G, Borger MA, Bouchard D, Bouchot O, Clark SC, Dapunt OE, Ferrarini M, Laufer G, Mignosa C, Millner R, Noirhomme P, Pfeiffer S, Ruyra-Baliarda X, Shrestha M, Suri RM, Troise G, Diegeler A, Laborde F, Laskar M, Najm HK, Glauber M.

Eur J Cardiothorac Surg. 2016 Mar;49(3):709-18. doi: 10.1093/ejcts/ezv369. Epub 2015 Oct 29.

PMID:
26516193
44.

A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytes.

McCarthy BA, Yancopoulos S, Tipping M, Yan XJ, Wang XP, Bennett F, Li W, Lesser M, Paul S, Boyle E, Moreno C, Catera R, Messmer BT, Cutrona G, Ferrarini M, Kolitz JE, Allen SL, Rai KR, Rawstron AC, Chiorazzi N.

Immunol Res. 2015 Dec;63(1-3):90-100. doi: 10.1007/s12026-015-8688-3.

PMID:
26318878
45.

Minimally invasive mitral valve repair using a semi-rigid annuloplasty ring with a new chordal sizing system: the Memo3D ReChord.

Glauber M, Ferrarini M, Miceli A.

Ann Cardiothorac Surg. 2015 May;4(3):298-300. doi: 10.3978/j.issn.2225-319X.2015.04.06. Review. No abstract available.

46.

Interleukin 21 Controls mRNA and MicroRNA Expression in CD40-Activated Chronic Lymphocytic Leukemia Cells.

De Cecco L, Capaia M, Zupo S, Cutrona G, Matis S, Brizzolara A, Orengo AM, Croce M, Marchesi E, Ferrarini M, Canevari S, Ferrini S.

PLoS One. 2015 Aug 25;10(8):e0134706. doi: 10.1371/journal.pone.0134706. eCollection 2015.

47.

Dealing with a stenotic bicuspid aortic valve: Is this still an off-label procedure for a sutureless valve?

Glauber M, Ferrarini M, Lio A, Miceli A.

J Thorac Cardiovasc Surg. 2015 Oct;150(4):858-9. doi: 10.1016/j.jtcvs.2015.07.049. Epub 2015 Jul 18. No abstract available.

48.

Rate of tuberculosis infection in children and adolescents with household contact with adults with active pulmonary tuberculosis as assessed by tuberculin skin test and interferon-gamma release assays.

Ferrarini MA, Spina FG, Weckx LY, Lederman HM, De Moraes-Pinto MI.

Epidemiol Infect. 2016 Mar;144(4):712-23. doi: 10.1017/S0950268815001727. Epub 2015 Aug 3.

PMID:
26234295
49.

Minimally invasive aortic valve replacement with a sutureless valve through a right anterior mini-thoracotomy versus transcatheter aortic valve implantation in high-risk patients.

Miceli A, Gilmanov D, Murzi M, Marchi F, Ferrarini M, Cerillo AG, Quaini E, Solinas M, Berti S, Glauber M.

Eur J Cardiothorac Surg. 2016 Mar;49(3):960-5. doi: 10.1093/ejcts/ezv210. Epub 2015 Jun 25.

PMID:
26113005
50.

Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment.

Morabito F, Cutrona G, Mosca L, D'Anca M, Matis S, Gentile M, Vigna E, Colombo M, Recchia AG, Bossio S, De Stefano L, Maura F, Manzoni M, Ilariucci F, Consoli U, Vincelli I, Musolino C, Cortelezzi A, Molica S, Ferrarini M, Neri A.

Leuk Res. 2015 Aug;39(8):840-5. doi: 10.1016/j.leukres.2015.05.005. Epub 2015 May 19.

PMID:
26038121

Supplemental Content

Loading ...
Support Center